เกี่ยวกับตอนนี้

ภาษาอังกฤษ
สหรัฐอเมริกา

สำเนาบทสนทนา 🔗

ค้นหาตอนที่ผ่านมา

ค้นหาตอนที่ผ่านมาของ Inside Biotech

ตอนอื่นๆ ใน PODCAST นี้

Serial entrepreneur Michael Heltzen, CEO of Exozymes, reveals how his NASDAQ-listed company is "liberating enzymes from cells" to create a new generation of chemical manufacturing. Instead of using living cells as factories, Exozymes isolates enzymatic pathways to work as pure chemistry—achieving e…
CEO of Vistagen, Shawn Singh, returns to Inside Biotech to discuss groundbreaking developments in intranasal therapeutics. Shawn shares exciting results from Vistagen’s fast-track phase 3 trials, explains how intranasal drug delivery bypasses limitations of traditional therapeutics relying on syste…
What actually makes a good mentor, and how do you find one who’s right for you? In this episode of Inside Biotech, new host Riley explores how mentorship shapes scientific careers, sharing five key principles for building strong mentor–mentee relationships. Drawing from personal experience, the con…
What if we’ve been focusing on the wrong cells in cancer? In this episode, Dr. Reginald Hill explains how fibroblasts, inflammation, and tissue stiffness shape tumor behavior and chemoresistance—and how mouse models, organoids, and microfluidic devices can turn those insights into better diagnostic…
In this episode, Gabriella Rubert joins the Biotech Connection Los Angeles team for a thoughtful conversation reflecting on her journey as a host of the Inside Biotech podcast. Together, they explore the challenges and rewards of science communication, the responsibility of making complex scientifi…
ข้อสงวนสิทธิ์: พอดแคสต์และอาร์ตเวิร์คที่ฝังอยู่ในหน้านี้มาจาก Daniel Arce, Bryan Jimenez, Danielle Luu, Stephanie Wu, Riley Elmer, Sanju Vardhan, Karishma Chhugani, Ethan Chung ซึ่งเป็นทรัพย์สินของเจ้าของและไม่มีส่วนเกี่ยวข้องหรือรับรองโดย Listen Notes, Inc.